Please login to the form below

Not currently logged in
Email:
Password:

Grünenthal's Harald Stock joins OvaScience board

Provides European expertise as fertility company looks to expand beyond US

Harald Stock, OvaScienceInfertility specialist OvaScience has appointed Harald Stock, CEO of German pharma firm Grünenthal, to its board of directors.

Stock, who has served in his position at Grünenthal since 2009, will provide US-based OvaScience with strong working knowledge of the European pharma market as the company looks to expand its global reach.

“The global fertility market is nearly 10 times larger than the US alone, and growing rapidly,” said Dr Michelle Dipp, CEO of OvaScience.

“Harald's expertise and success commercialising products in global healthcare markets will be important to OvaScience as we advance our ex-US strategy.”

Prior to joining Grünenthal, Stock was chairman and managing director of the German DePuy Group, the orthopaedics division of Johnson & Johnson.

He has also spent time with Roche, serving in a variety of senior positions, including senior VP of its  global near patient testing business.

In addition, Stock is a board member of EFPIA and previously represented J&J on the board of BVMed, the body representing the medical technology industry in Germany.

12th February 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Free White Paper: Customer Experience for Pharma
To learn why an effective customer experience strategy is vital for pharma, download our white paper “Customer experience for pharma” to learn more....
How ethical is your brand plan? Introducing the hEQ.
Assess your brand plan’s Healthcare Ethics Quotient and see how these questions can give your brand plan a new perspective and engage your internal teams and external customers....
solution_options.png
Why e-detailing must give options to healthcare professionals
We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible....